Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 31 n° 301

Moderna Named a Top Employer by Science for the Fourth Consecutive Year

Posted by fidest press agency su sabato, 27 ottobre 2018

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced it has been named one of the global biopharmaceutical industry’s top employers in Science and Science Careers’ 2018 Top Employers Survey. This is the fourth consecutive year Moderna has been selected and this year the company was ranked 4th. The annual employee survey evaluates companies in biotechnology, biopharmaceutical, pharmaceutical and other related industries in categories such as leadership in innovation, alignment between work culture and values and commitment to social responsibility.
“It is an honor to be recognized as a top employer by Science and to be included amongst this group of industry leaders,” said Stéphane Bancel, CEO at Moderna. “As a mission-driven company, we work to attract exceptional team members who are passionate about delivering on the potential of our mRNA science for patients. Our R&D leadership has built an organization where professional and growth opportunities are matched by a commitment to continuous innovation and scientific excellence, and have fostered our company’s culture of respect for the individual, community and citizenship, and where employee feedback is a core component of decision making.” Moderna earlier this month introduced a range of enhanced benefits, including 16 weeks of paid parental leave and 16 weeks of caregiver leave, and a sabbatical program that offers four weeks of paid time off after five years of full-time employment with the company. These programs complement Moderna’s existing benefits which include extensive healthcare coverage, paid time off for volunteering and subsidized childcare.The Science and Science Careers’ 2018 survey findings are based on 8,015 completed surveys from readers of Science and other survey invitees. Survey respondents came from North America (63%), Europe (24%), and Asia/Pacific Rim (9%); 93% work in biotechnology, biopharmaceutical, and pharmaceutical companies. The complete feature can be found online on the ScienceCareers.org website and in the October 26, 2018 print issue of Science.

Rispondi

Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo WordPress.com

Stai commentando usando il tuo account WordPress.com. Chiudi sessione /  Modifica )

Google photo

Stai commentando usando il tuo account Google. Chiudi sessione /  Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione /  Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione /  Modifica )

Connessione a %s...

 
%d blogger hanno fatto clic su Mi Piace per questo: